# EBANGA
> **BLA761172** · Biologics License Application · Sponsor: RIDGEBACK BIOTHERAPEUTICS · Approved 2020-12-21
## Drug
- **FDA Application Number:** BLA761172
- **Application type:** Biologics License Application
- **Brand name:** EBANGA
- **Generic name:** ANSUVIMAB
- **Active ingredients:** ANSUVIMAB-ZYKL
- **Dosage form:** POWDER
- **Route:** IV (INFUSION)
- **Marketing status:** Prescription
- **Sponsor:** RIDGEBACK BIOTHERAPEUTICS
- **Manufacturer:** Emergent Manufacturing Operations Baltimore, LLC
- **First approval:** 2020-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761172)
---
*AI Analytics · CC0 1.0*